Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine nerve block in facial trauma surgery
NCT06429501Phase 2Recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2024
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine in pain, sponsored by Washington University School of Medicine. Started Apr 2024; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
pain
Beyond the preview
Go deeper on NCT06429501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06429501.